December 12, 2019 – The RSA Group, which is based in London and focuses on the life sciences sector, has named Kristian Jürgensen as chief commercial officer, effective immediately. In his new role, Mr. Jürgensen is charged with ensuring that all functions of the organization are aligned to meet strategic commercial objectives and will continue to drive business growth.
“I have been incredibly impressed with Kristian’s drive and determination since he came back to us in May this year,” said Nick Stephens, executive chairman of The RSA Group. “He understands the industry, has a wealth of experience in executive search and interim management as well as general business management and consultancy which will continue to be of enormous value to our clients at RSA.”
Mr. Jürgensen joined the firm as managing partner for Germany and Switzerland in May and has proved himself to be a driver of growth and focus at the company. “Recognizing that client satisfaction is The RSA Group’s greatest asset, an important part of Kristian’s role will be listening to clients and leading a continuous process improvement model,” the search firm said.
Before re-joining The RSA Group, Mr. Jürgensen was head of DACH, pharmaceutical and biotech EMEA with Carmichael Fisher Executive Search. Earlier in his career, he was head of tender management at a leading generics company. Mr. Jürgensen is a qualified lawyer certified in pharmaceutical law, he holds an MBA and is fluent in German and English. He has over 18 years’ experience in the consultancy and executive search sector.
“I’m delighted to be stepping up into my new role as chief commercial officer,” Mr. Jürgensen said. “I enjoy working with the highly talented team at The RSA Group and developing new areas of focus to help drive the company forward during this exciting phase of growth and expansion.”
Sector In Transition
The RSA Group advises on the selection, assessment and onboarding of board and senior executive talent for the life sciences. Specializing in C-suite, senior executive and board-level searches, its clients include global industry leaders through to start-up businesses. RSA Group operates in pharmaceuticals, biotechnology, medical devices, diagnostics, generics, consumer healthcare, animal health, service organizations, venture capital, charities and academic medical research. Established in 1981, the firm has offices in the U.S., U.K., Germany, Switzerland, Turkey, Singapore and China.
Closing the Deal with Candidates in the Life Sciences Sector
The competitive landscape of the life sciences industry is transforming recruiting. “Growing pressure to rapidly advance scientific discovery and expand market share is making the competition to attract top talent as fierce as ever,” according to a report by Dan Strauss, head of the pharmacovigilance and risk management practice at Klein Hersh International.
According to Deloitte’s global sector outlook report on life sciences, persistent talent shortages and the need to develop and retain employees with critical business and technology skill-sets will continue to challenge global life sciences companies as they try to navigate a new world of work. This will require a dramatic change in strategies for leadership, talent and human resources.
“Our sector has changed beyond anyone’s expectations over the last two decades,” said Ms. Coulter. “We need to understand the appetites and needs of the major multinationals. This requires reach into all corners of the market. While our office network is growing, the key has been to have multilingual, multi-market experienced and connected researchers and consultants. Our team speaks many languages and has worked in all major bio-pharma markets and is organized as one P&L, to ensure collaborative information and experience sharing.”
Contributed by Scott A. Scanlon, Editor-in-Chief; Dale M. Zupsansky, Managing Editor; and Stephen Sawicki, Managing Editor – Hunt Scanlon Media